Personal care company Edgewell Personal Care (NYSE: EPC) will be announcing earnings results this Wednesday before the bell. Here’s what investors should know.
Edgewell Personal Care met analysts’ revenue expectations last quarter, reporting revenues of $519.5 million, flat year on year. It was a very strong quarter for the company, with a solid beat of analysts’ EBITDA estimates and an impressive beat of analysts’ organic revenue estimates.
Is Edgewell Personal Care a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.
This quarter, the market is expecting Edgewell Personal Care’s revenue to grow 3% year on year, a reversal from the 13.5% decrease it recorded in the same quarter last year.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business will stay the course heading into earnings.
Looking at Edgewell Personal Care’s peers in the consumer staples segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Medifast’s revenues decreased 27.6% year on year, beating analysts’ expectations by 5.1%, and Vita Coco reported revenues up 28.1%, topping estimates by 3%. Vita Coco traded down 11.4% following the results.
Read our full analysis of Medifast’s results here and Vita Coco’s results here.
Investors in the consumer staples segment have had steady hands going into earnings, with share prices up 1.4% on average over the last month. Edgewell Personal Care is up 3.5% during the same time and is heading into earnings with an average analyst price target of $28 (compared to the current share price of $27.61).
WHILE YOU’RE HERE: The Next Palantir? One satellite company captures images of every point on Earth. Every single day. The Pentagon wants it. Hedge funds are using it to beat earnings. You’ve probably never heard of it.
This is what the early days of Palantir looked like before it became a giant. Same playbook. Different technology. If you missed Palantir, you need to see this. Claim The Stock Ticker for Free HERE.
